News

On May 11, 2026, Fractyl Health announced that it has obtained approval for a clinical trial application in the Netherlands and will initiate the f...

On May 8, 2026, Anjin registered the GIPR antibody coupled GLP-1 new drug AMG 133 (Maridebart Caffraglutide) on the Clinicaltrials.gov website for ...

On January 28, 2026, Shandong Shengdi Pharmaceutical Co., Ltd., a subsidiary of Hengrui Pharmaceutical, received the "Drug Clinical Trial Appr...

On January 26, 2026, Geli Pharmaceutical Co., Ltd. (Hong Kong Stock Exchange Code: 1672, referred to as "Geli") announced today that its ...

Recently, Anlong Biotechnology and Sunshine Novo jointly announced that the clinical trial application for the innovative hypertension drug ABA001,...

Great discount, BLOOM TECH!!! (Updated on Sep. 17th 2025) We supply: (1)Lyophilized & Blends peptides, Vials and Pens. (2)Peptide Tablets, caps...

On October 13, 2025, Shiyao Group (1093. HK) announced that its subsidiary, Shiyao Group Baike (Shandong) Biopharmaceutical Co., Ltd., has received...

Recently, Rein Therapeutics (referred to as "Rein", NASDAQ stock code: RNTX), a biopharmaceutical company, announced that it has been aut...

On October 9, 2025, Chengdu Newruit Medical Technology Co., Ltd. (hereinafter referred to as Newruit Medical) recently completed a Series D financi...

On September 29, 2025, Metsera (acquired by Pfizer) announced positive results from two weight loss phase 1b studies (VESPER-1 and VESPER-13) of ME...

On September 29, 2025, Hangzhou Yaoaccelerated Medical Isotope Technology Co., Ltd. (hereinafter referred to as "Yaoaccelerated"), a hard...

We recently successfully obtained an order of retatrutide products from a German client, further expanding our business footprint in the European m...